company background image
HNL logo

Dr. Hönle Informe acción XTRA:HNL

Último precio

€19.85

Capitalización de mercado

€120.3m

7D

-0.7%

1Y

2.6%

Actualizada

01 May, 2024

Datos

Finanzas de la empresa +

Dr. Hönle AG

Informe acción XTRA:HNL

Capitalización de mercado: €120.3m

Resumen de acción HNL

Dr. Hönle AG se dedica al suministro de tecnologías y sistemas UV industriales en Alemania y a escala internacional.

Acerca de la empresa

HNL fundamental analysis
Snowflake Score
Valuation1/6
Future Growth4/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Recompensas

Se prevé un crecimiento anual de los beneficios de 148.95%

Análisis de riesgos

Los pagos de intereses no están bien cubiertos por los beneficios

Competidores de Dr. Hönle AG

FRIWO

XTRA:CEA

€191.6m

Varta

XTRA:VAR1

€399.3m

SFC Energy

XTRA:F3C

€328.5m

SBF

DB:CY1K

€36.7m

Historial de precios y rendimiento

Summary of all time highs, changes and price drops for Dr. Hönle
Historical stock prices
Current Share Price€19.85
52 Week High€24.50
52 Week Low€15.00
Beta1.48
1 Month Change2.85%
3 Month Change18.15%
1 Year Change2.58%
3 Year Change-57.86%
5 Year Change-62.41%
Change since IPO14.81%

Noticias y actualizaciones recientes

Dr. Hönle AG's (ETR:HNL) Popularity With Investors Is Clear

Feb 08
Dr. Hönle AG's (ETR:HNL) Popularity With Investors Is Clear

Recent updates

Dr. Hönle AG's (ETR:HNL) Popularity With Investors Is Clear

Feb 08
Dr. Hönle AG's (ETR:HNL) Popularity With Investors Is Clear

We Think Dr. Hönle (ETR:HNL) Has A Fair Chunk Of Debt

Oct 11
We Think Dr. Hönle (ETR:HNL) Has A Fair Chunk Of Debt

Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?

Aug 07
Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?

Is Dr. Hönle (ETR:HNL) A Risky Investment?

Jun 03
Is Dr. Hönle (ETR:HNL) A Risky Investment?

The Returns On Capital At Dr. Hönle (ETR:HNL) Don't Inspire Confidence

Nov 03
The Returns On Capital At Dr. Hönle (ETR:HNL) Don't Inspire Confidence

Dr. Hönle (ETR:HNL) Has No Shortage Of Debt

Sep 29
Dr. Hönle (ETR:HNL) Has No Shortage Of Debt

There Are Reasons To Feel Uneasy About Dr. Hönle's (ETR:HNL) Returns On Capital

Jul 06
There Are Reasons To Feel Uneasy About Dr. Hönle's (ETR:HNL) Returns On Capital

Capital Allocation Trends At Dr. Hönle (ETR:HNL) Aren't Ideal

Feb 20
Capital Allocation Trends At Dr. Hönle (ETR:HNL) Aren't Ideal

Dr. Hönle AG (ETR:HNL) Shares Could Be 37% Below Their Intrinsic Value Estimate

Jul 15
Dr. Hönle AG (ETR:HNL) Shares Could Be 37% Below Their Intrinsic Value Estimate

Is Dr. Hönle (ETR:HNL) A Risky Investment?

Jun 14
Is Dr. Hönle (ETR:HNL) A Risky Investment?

Is Dr. Hönle AG (ETR:HNL) Potentially Undervalued?

May 30
Is Dr. Hönle AG (ETR:HNL) Potentially Undervalued?

Dr. Hönle (ETR:HNL) Could Be Struggling To Allocate Capital

May 17
Dr. Hönle (ETR:HNL) Could Be Struggling To Allocate Capital

Calculating The Fair Value Of Dr. Hönle AG (ETR:HNL)

Mar 29
Calculating The Fair Value Of Dr. Hönle AG (ETR:HNL)

Do Investors Have Good Reason To Be Wary Of Dr. Hönle AG's (ETR:HNL) 1.0% Dividend Yield?

Mar 16
Do Investors Have Good Reason To Be Wary Of Dr. Hönle AG's (ETR:HNL) 1.0% Dividend Yield?

We Think Dr. Hönle (ETR:HNL) Is Taking Some Risk With Its Debt

Mar 03
We Think Dr. Hönle (ETR:HNL) Is Taking Some Risk With Its Debt

Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?

Feb 20
Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?

We Wouldn't Rely On Dr. Hönle's (ETR:HNL) Statutory Earnings As A Guide

Feb 08
We Wouldn't Rely On Dr. Hönle's (ETR:HNL) Statutory Earnings As A Guide

Did Business Growth Power Dr. Hönle's (ETR:HNL) Share Price Gain of 131%?

Jan 25
Did Business Growth Power Dr. Hönle's (ETR:HNL) Share Price Gain of 131%?

Should We Be Excited About The Trends Of Returns At Dr. Hönle (ETR:HNL)?

Jan 11
Should We Be Excited About The Trends Of Returns At Dr. Hönle (ETR:HNL)?

What Kind Of Investors Own Most Of Dr. Hönle AG (ETR:HNL)?

Dec 27
What Kind Of Investors Own Most Of Dr. Hönle AG (ETR:HNL)?

Dr. Hönle AG (ETR:HNL) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Dec 15
Dr. Hönle AG (ETR:HNL) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Is Dr. Hönle AG (ETR:HNL) An Attractive Dividend Stock?

Dec 03
Is Dr. Hönle AG (ETR:HNL) An Attractive Dividend Stock?

These 4 Measures Indicate That Dr. Hönle (ETR:HNL) Is Using Debt Extensively

Nov 22
These 4 Measures Indicate That Dr. Hönle (ETR:HNL) Is Using Debt Extensively

Rentabilidad de los accionistas

HNLDE ElectricalMercado DE
7D-0.7%5.0%-1.2%
1Y2.6%-9.3%1.8%

Rentabilidad vs. Industria: HNL superó al sector German Electrical , que obtuvo un rendimiento del -11.3% el año pasado.

Rentabilidad vs. Mercado: HNL igualó el mercado German, que obtuvo un rendimiento del 2.2% el año pasado.

Volatilidad de los precios

Is HNL's price volatile compared to industry and market?
HNL volatility
HNL Average Weekly Movement4.2%
Electrical Industry Average Movement5.0%
Market Average Movement4.9%
10% most volatile stocks in DE Market10.2%
10% least volatile stocks in DE Market2.4%

Precio estable de las acciones: HNL no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de HNL (4%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

FundadaEmpleadosCEOPágina web
1976581Franz Richterwww.hoenle.de

Dr. Hönle AG se dedica al suministro de tecnologías y sistemas UV industriales en Alemania y a escala internacional. La empresa opera a través de tres segmentos: Adhesivos, Equipos y Sistemas, y Vidrio y Lámparas. El segmento de Adhesivos suministra adhesivos industriales para aplicaciones como electrónica de consumo, automoción, óptica y optoelectrónica, tecnología médica y procesamiento de vidrio.

Resumen de fundamentos de Dr. Hönle AG

¿Cómo se comparan los beneficios e ingresos de Dr. Hönle con su capitalización de mercado?
Estadísticas fundamentales de HNL
Capitalización bursátil€120.33m
Beneficios(TTM)-€13.83m
Ingresos (TTM)€102.56m

1.2x

Ratio precio-ventas (PS)

-8.7x

Ratio precio-beneficio (PE)

¿Está HNL sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de HNL
Ingresos€102.56m
Coste de los ingresos€41.13m
Beneficio bruto€61.43m
Otros gastos€75.26m
Beneficios-€13.83m

Últimos beneficios comunicados

Dec 31, 2023

Próxima fecha de beneficios

May 08, 2024

Beneficios por acción (BPA)-2.28
Margen bruto59.90%
Margen de beneficio neto-13.48%
Ratio deuda/patrimonio56.3%

¿Cómo se ha desempeñado HNL a largo plazo?

Ver rendimiento histórico y comparativa